Fig. 1 · Structure
Documents & Downloads
(R)-JD-5037
CBi Antagonist
(R)-JD-5037 is a CBi receptor antagonist known for its potential in modulating cannabinoid signaling pathways. While exhibiting an IC50 value greater than 1 μM, this compound serves as a valuable tool in researching the roles of CBi receptors in various biological processes. Its utility extends to studies aimed at understanding the therapeutic implications of cannabinoid modulation in conditions such as pain, inflammation, and neurodegenerative diseases.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 1404117-65-2 |
| Applications | CBi Antagonist |
| Formula | C27H27Cl2N5O3S |
| Molecular Weight | 572.51 |
| SMILES | NC([C@H](C(C)C)/N=C(NS(=O)(C1=CC=C(Cl)C=C1)=O)\N2N=C(C3=CC=C(Cl)C=C3)[C@H](C4=CC=CC=C4)C2)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.